Related Experiment Video
Updated: Nov 5, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Long-Term Clinical Impact of Cardiogenic Shock and Heart Failure on Admission for Acute Myocardial Infarction
Hideki Wada1, Manabu Ogita1, Satoru Suwa1
1Department of Cardiology, Juntendo University Shizuoka Hospital.
Insights
Patients with cardiogenic shock (CS) after acute myocardial infarction (AMI) have worse long-term outcomes. Early heart failure (HF) without CS also impacts survival, necessitating focused care for better long-term AMI outcomes.
Area of Science:
- Cardiology
- Clinical Outcomes Research
- Acute Myocardial Infarction
Background:
- Long-term outcomes for acute myocardial infarction (AMI) patients surviving cardiogenic shock (CS) and heart failure (HF) are not well-defined.
- Understanding post-discharge prognosis is crucial for managing these high-risk patients.
Purpose of the Study:
- To evaluate the long-term clinical outcomes of AMI patients with and without CS.
- To identify factors associated with 30-day mortality in AMI patients with CS.
- To compare long-term mortality between AMI patients with CS, those with HF but no CS, and those with neither.
Main Methods:
- Analysis of 3263 AMI patients from the prospective J-MINUET registry (Japan, 2012-2014).
- Patients categorized into CS-/HF-, CS-/HF+, and CS+ groups.
- Multivariate logistic and Cox hazard regression models used to assess 30-day and long-term mortality, respectively.
Main Results:
- Thirty-day mortality was 32.8% in the CS+ group.
- Pre-admission statin use, renal deficiency, and final thrombolysis in myocardial infarction flow grade were associated with 30-day mortality in CS+ patients.
- Long-term mortality (up to 3 years) was comparable between CS+ and CS-/HF+ groups, and significantly higher than in the CS-/HF- group.
Conclusions:
- AMI patients with CS who survive the initial 30 days face worse long-term outcomes compared to those without CS.
- Patients with heart failure but no cardiogenic shock also have poorer long-term prognosis than those without HF or CS.
- Clinical attention should focus on improving long-term outcomes for AMI patients, particularly those presenting with HF without CS.
Abstract:
Long-term clinical outcomes among patients with cardiogenic shock (CS) and heart failure (HF) who survive the early phase of acute myocardial infarction (AMI) remain uncertain. We investigated 3283 consecutive patients with AMI, selected from a prospective, nation-wide multicenter registry (J-MINUET) database comprising 28 institutions in Japan between July 2012 and March 2014. The 3263 eligible patients were divided into the following three groups: CS-/HF- group (n = 2467, 75.6%); CS-/HF+ group (n = 479, 14.7%); and CS+ group (n = 317, 9.7%). The thirty-day mortality rate in CS+ patients was 32.8%, significantly higher than in CS- patients. Among CS+ patients, multivariate logistic regression analysis identified statin use before admission (Odds ratio (OR) 0.32, 95% confidence interval (CI) 0.14-0.66, P = 0.002), renal deficiency (OR 8.72, 95%CI 2.81-38.67, P < 0.0001) and final thrombolysis in myocardial infarction flow grade (OR 0.42, 95%CI 0.18-0.99, P = 0.046) were associated with 30-day mortality. Landmark Kaplan-Meier analysis showed that mortality rates after 30 days were comparable between CS+ and CS-/HF+ groups but were lower in the CS-/HF- group. Multivariate Cox hazard analysis also showed that hazard risk of mortality after 30 days was comparable between the CS+ and CS-/HF+ groups (Hazard ratio (HR) 1.03, 95%CI 0.63-1.68, P = 0.90), and significantly lower in the CS-/HF- group (HR 0.44, 95%CI 0.32-059, P < 0.0001). In conclusion, AMI patients with CS who survived 30 days experienced worse long-term outcomes compared with those without CS up to 3 years. Attention is required for patients who show HF on admission without CS to improve long-term AMI outcomes.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Myocarditis I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Acute Coronary Syndrome III: Diagnostic Studies
Heart Failure I: Introduction

